Systematic Literature Review for EU MDR

Global Medical Device Podcast · 5 Apr 2023 · 38m · Episode 313

What this episode covers

Ethan Drower, Co-Founder and Operating Partner of CiteMed, explains the rigorous process of conducting systematic literature reviews for EU MDR Clinical Evaluation Reporting (CERs). He details how the EU MDR has shifted scrutiny from equivalence to empirical data, requiring manufacturers to search multiple databases like PubMed and Embase to prove device safety. Drower highlights common pitfalls, such as starting too late and failing to maintain continuous post-market surveillance, while advocating for software tools to manage the volume of clinical data.

Mentioned

Companies
CiteMed, Greenlight Guru
Also
PubMed, Embase, Cochrane Library, clinicaltrials.gov, EU MDR, FDA

Other shows on the same ground, closest first.

  • Let's Combinate · 41m

    059 - Literature Review, EU MDR CER’s, and Being Problem Driven with Ethan Drower

    Ethan Drower, Co-Founder of CiteMed, explains how his company uses software to streamline the literature review process for EU MDR Clinical Evaluation Reports (CERs). He details the shift from ad-hoc searches to rigorous, reproducible protocols required by notified bodies, emphasizing the need to track search results and maintain continuous risk-benefit assessments. Drower discusses the operational challenges of managing large portfolios of devices and the importance of validating software tools to ensure compliance and efficiency in regulatory submissions.

  • Let's Combinate · 17m

    069 - EU MDR Extension with Michelle Lott

    Michelle Lott, founder of leanRAQA, explains that the EU MDR extension is not a simple delay but a conditional pathway for companies that have actively transitioned their quality systems. She details two routes to extend certificates: submitting to national competent authorities or obtaining derogation from notified bodies, both requiring proof of effort and capacity constraints. Lott highlights that over 50% of technical files are rejected initially and notes that notified bodies are now selective, preferring clients who are prepared and easy to work with.

  • Let's Combinate · 1h 29m

    015 - "Would You Use it on a Family Member?" with Monir El Azzouzi

    Monir El Azzouzi of Easy Medical Device explains the transition from the EU Medical Device Directive (MDD) to the Medical Device Regulation (MDR), highlighting the shift from self-certification to notified body oversight and the impact on private labeling. He details the structural differences between US FDA pathways (510k, PMA) and EU classification rules, noting that MDR requires full technical files for brand owners rather than just distributors. El Azzouzi also discusses the role of notified bodies, the conflict of interest preventing them from offering pre-submission guidance, and the importance of the 'would you use it on your family?' mantra in quality assurance.

  • Let's Combinate · 40m

    099 - Medical Device vs. Medicinal Product Reviews in the EU, Working at MHRA, Notified Bodies, EU MDR, ICH Q6 and Writing All About It with Janine Jamieson

    Janine Jamieson, European Editor at International Pharmaceutical Quality, explains the regulatory complexities of drug-device combination products in the EU, detailing her tenure as a pharmaceutical assessor at the UK MHRA. She describes the historical challenges of reviewing device-led products without clear pathways, which led to the introduction of Article 117 in the EU MDR to balance device and medicinal product reviews. The conversation covers the current state of notified bodies, the upcoming New Falsified Medicines Directive (New FMD), and the revision of ICH Q6 specifications to decouple safety from manufacturing capability.

  • Let's Combinate · 28m

    054 - "EUDAMED" with Richard Houlihan

    Richard Houlihan, CEO of Eirmed, discusses the history, structure, and compliance requirements of EUDAMED, the European Commission's medical device database. He details the system's six modules, highlighting the complexity of the clinical investigations module and the shift from private competent authority access to public transparency for device data. Houlihan explains the legal obligations for economic operators, including manufacturers, authorized representatives, and importers, emphasizing that EUDAMED is a mandatory cost of doing business in Europe with strict data validation rules.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.